---
title: 'FDA Public Meetings #1: Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask'
author: ''
date: '2022-06-30T08:00:00'
slug: fda-public-meetings-1-using-methods-from-pfdd-guidance-1-and-guidance-2-as-tools-for-including-patient-experience-data-in-clinical-trials
categories: []
tags: []
type: webinar
url_freeregister: https://www.eventbrite.com/e/patient-experience-data-in-clinical-trials-who-to-ask-and-how-to-ask-tickets-360610133617
url_register: ~
url_slides: ~
url_video: no
url_agenda: ~
url_website: https://content.govdelivery.com/accounts/USFDA/bulletins/31c119d
url_audio: ~
url_code: ~
url_pdf: ~
date_end: '2022-06-30T10:00:00'
all_day: no
publishDate: '2022-06-22T10:02:48-07:00'
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
slides: ''
projects: []
location: ~
address:
  street: ~
  city: ~
  region: ~
  postcode: ~
  country: ~
summary: ~
abstract: ~
speaker: ~
---

<!--more-->
Speakers and participants will discuss a range of issues and best practices related to collecting patient input, selecting data collection methods, and developing sampling plans and strategies. External stakeholders will present examples of how they have used the guidance documents as tool to inform their collection of patient data. You may find a link to the referenced guidance documents here: [PFDD Methodologic Guidance Documents](http://wcms-internet.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical?utm_medium=email&utm_source=govdelivery)